| Tue, Dec 1, 2009 | | • | DiaMedica Proposes to Expand Into Neurological and Other Disorders Through Acquisition of Sanomune
CCNMatthews (Tue, Dec 1)
| | Thu, Jul 30, 2009 | | • | DiaMedica Founder Invited to Speak at International Scientific Conference
CCNMatthews (Thu, Jul 30)
| | Wed, Jul 29, 2009 | | • | DiaMedica Announces Executive Management Change
CCNMatthews (Wed, Jul 29)
| | Tue, Jun 2, 2009 | | • | DiaMedica Retains Leading Investor Relations Firm
CCNMatthews (Tue, Jun 2)
| | • | DiaMedica Retains Leading Investor Relations Firm
Marketwire (Tue, Jun 2)
| | Tue, Apr 14, 2009 | | • | DiaMedica Grants Options to Board Members
CCNMatthews (Tue, Apr 14)
| | • | DiaMedica Grants Options to Board Members
Marketwire (Tue, Apr 14)
| | Thu, Apr 9, 2009 | | • | DiaMedica Receives Financial Contribution From the National Research Council of Canada to Develop DM-99 Program for the Treatment of Type 2 Diabetes
CCNMatthews (Thu, Apr 9)
| | Tue, Mar 31, 2009 | | • | DiaMedica Announces Topline Results From DM-99 Phase IIa Study in Type 2 Diabetes
CCNMatthews (Tue, Mar 31)
| | Mon, Mar 9, 2009 | | • | DiaMedica Appoints Stephen J. Waters as Interim Chief Scientific Officer
CCNMatthews (Mon, Mar 9)
| | Tue, Feb 10, 2009 | | • | DiaMedica Announces Last Patient Out for DM-99 Phase IIa Human Clinical Trial
CCNMatthews (Tue, Feb 10)
| | Thu, Feb 5, 2009 | | • | DiaMedica Inc. Announces New CEO; Experienced Pharmaceutical Executive to Lead Company
CCNMatthews (Thu, Feb 5)
| | Mon, Jan 26, 2009 | | • | DiaMedica to Present at US Investment Forums
CCNMatthews (Mon, Jan 26)
| | Thu, Jan 15, 2009 | | • | DiaMedica Cleared to Initiate Its Second Phase II Clinical Trial of DM-71 in Patients With Type 2 Diabetes
CCNMatthews (Thu, Jan 15)
| | Tue, Jan 13, 2009 | | • | DiaMedica Announces Richard D. Pilnik to Join Board of Directors
CCNMatthews (Tue, Jan 13)
|
Add DMA.V News to My Yahoo!:
 
| |
|
0.03% Nasdaq 
Headlines
